Rua Bioscience extends rights offer deadline to ensure shareholder participation

Rua Bioscience has extended the closing date for its pro rata renounceable rights offer from Friday, November 28, 2025, to Friday, December 12, 2025. This extension aims to ensure all eligible shareholders have the opportunity to participate. The rights trading period on the NZX Main Board will now close on Monday, December 8, 2205, instead of November 24, 2025.

The rights issue allows existing shareholders to subscribe for 1 new share for every 3 shares held at the record date of 5pm, Monday, November 10, 2025. The exercise price is NZ$0.025 per new share, payable in full on application. The company aims to drive positive change in the medicinal cannabis industry.

Following the extension, the announcement of the offer results will shift to Tuesday, December 16, 2025, with the issue date and quotation of new shares on the NZX Main Board set for Thursday, December 18, 2025. Computershare Investor Services Limited is the registrar for this offer.